Johnson & Johnson
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $5.53B | $5.24B | $5.12B | $5.15B | $5.54B | $11.00B | $3.43B | $2.69B |
| Depreciation & Amortization | $1.96B | $2.00B | $2.01B | $1.78B | $1.94B | $1.77B | $1.90B | $1.85B |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $1.20B | $1.20B | $1.20B | $1.00B | $1.30B | $1.10B | $1.10B | $1.20B |
| Stock-Based Compensation | $458.0M | $300.0M | $309.0M | $347.0M | $410.0M | $288.0M | $238.0M | $295.0M |
| Net Cash from Operating Activities | $8.62B | $2.51B | $7.31B | $9.17B | $3.88B | $4.17B | $6.98B | $7.99B |
| Investing Activities | ||||||||
| Capital Expenditures | $1.32B | $1.05B | $1.84B | $1.16B | $1.04B | $795.0M | $1.61B | $1.03B |
| Business Acquisitions | $-17.24B | $17.50B | $3.08B | $1.0M | $14.46B | $0 | $1.0M | $338.0M |
| Net Cash from Investing Activities | $-1.11B | $-1.04B | $-4.49B | $-542.0M | $-18.26B | $-297.0M | $-1.32B | $-3.13B |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $221.0M | $4.03B | $1.92B | $1.90B | $0 | $2.13B | $282.0M | $539.0M |
| Net Cash from Financing Activities | $-8.78B | $530.0M | $-1.37B | $-8.93B | $-5.67B | $10.42B | $-1.34B | $-9.88B |
| Net Change in Cash | $-1.27B | $1.98B | $1.48B | $-346.0M | $-19.90B | $14.37B | $4.13B | $-4.90B |
| Free Cash Flow | $7.30B | $1.47B | $5.47B | $8.01B | $2.84B | $3.38B | $5.37B | $6.96B |